Trueblood Wealth Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Sell
4,208
-2,454
-37% -$224K 0.13% 182
2026
Q1
$684K Buy
6,662
+29
+0.4% +$3.27K 0.27% 117
2025
Q4
$831K Sell
6,633
-109
-2% -$13.9K 0.32% 97
2025
Q3
$903K Buy
6,742
+17
+0.3% +$2.23K 0.35% 96
2025
Q2
$915K Buy
6,725
+654
+11% +$86.2K 0.38% 86
2025
Q1
$805K Buy
6,071
+105
+2% +$13.4K 0.37% 94
2024
Q4
$675K Buy
5,966
+378
+7% +$43.7K 0.33% 103
2024
Q3
$637K Buy
5,588
+232
+4% +$25.4K 0.32% 99
2024
Q2
$557K Buy
5,356
+8
+0.1% +$848 0.31% 100
2024
Q1
$608K Buy
5,348
+1
+0% +$115 0.35% 94
2023
Q4
$589K Buy
+5,347
New +$534K 0.37% 89

Other funds holding ABT

Trueblood Wealth Management's ABT Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Abbott (ABT) stake by 37% in Q2 2026, selling an estimated $224K and leaving 4,208 shares worth $382K. The position accounts for 0.13% of the portfolio, ranked #182.

Trueblood Wealth Management first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $915K in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Trueblood Wealth Management held 4,208 shares of Abbott worth $382K as of Q2 2026.
  • Trueblood Wealth Management sold 2,454 Abbott shares in Q2 2026, an estimated $224K.
  • Abbott made up 0.13% of Trueblood Wealth Management's portfolio in Q2 2026, its #182 holding.
  • Trueblood Wealth Management first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Abbott position peaked at $915K in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.